ACS Applied Materials & Interfaces · 2020 · 20 citations · 45 references
Life SciencesBiochemistryPharmacologyCancer PharmacologyProtein FoldingStructural BiologyCell-penetrating PeptidesLipid RaftsLipid-protein InteractionsMembrane ProteinsPeptide ChemistryProtein StructureAnticancer ActivityCoiled-coil ScaffoldsHydrophobic PeptidesMembrane Protein PalmitoylationMembrane Translocation MechanismsNecroptotic SignalingPeptide Structure - Activity RelationshipsPh-dependent Folding
-palmitoylated MK5E (P1MK5E) and MEK5 (P1MEK5) that have the same composition of 23 residues undergoing the pH-dependent structural alterations but differ in the conformational tendency of their amino acid composites. Nonlipidated peptides were readily accumulated in the A549 cell nucleus by the direct membrane translocation and the heparan sulfate-mediated endocytosis than the lipid-raft-dependent pathway. The increased hydrophobicity favored the amino acid-position-dependent folding of P1MK5E and P1MEK5, respectively, toward the α-helical coiled-coil nanofibrils and amyloidlike β-protofibrils. At the close concentrations (∼7.5 μM) to the toxic effects of doxorubicin (DOX), P1MK5E exhibited (i) an increased anticancer toxicity through a time-dependent S-phase arrest, (ii) enhanced plasma membrane permeability, and (iii) dose-dependent changes in the cell death characteristic features in the A549 cells relative to P1MEK5 that was almost inactive at ∼75 μM. These observations were in accordance with the TNF-α-mediated necroptotic signaling in the c-MYC/PARP1-overexpressed A549 cells exposed to P1MK5E and accompanied by the ultrastructure of plasma membrane protrusions, extensive endoplasmic reticulum (ER) membrane expansion, mitochondrial swelling, and the formation of distinct cytoplasmic vacuolation. The structural results and the bioactivity behaviors, herein, declared the significance of α-helical propensity in the peptide sequence and the nanostructure morphologies of self-assembling ACLPs upon the selectivity and enhanced anticancer effectiveness, which notably holds promise in the design and development of efficient therapeutics for cancer.
45
Vasanth V Ranade · American Journal of Therapeutics · 2009 · 2.8K citations
Selvi Bharathavikru, Tatiana Dudnakova · 2016 · 953 citations
c-Myc Can Induce DNA Damage, Increase Reactive Oxygen Species, and Mitigate p53 Function
Omid Vafa, Mark Wade, S Kern et al. · Molecular Cell · 2002 · 871 citations · Full text